The U.S. Food and Drug Administration has given Medtronic (NYSE:MDT) the go-ahead on a clinical trial to test its next generation of MRI pacemaker technology, the Minnesota company announced Monday.

CHICAGO — One person’s used pacemaker is another person’s treasure. A program to refurbish used pacemakers could expand access to the lifesaving devices. In a clinical trial of nearly 300 people, ...

Cardiac implantable electronic devices (CIEDs) constitute a major breakthrough in the management of heart rhythm disorders. These devices largely include bradycardia pacemakers, biventricular ...

This story is part of a series on the current progression in Regenerative Medicine. This piece discusses the regeneration of the cardiovascular system. In 1999, I defined regenerative medicine as the ...

Munich, Germany - In a recent study evaluating the safety of airport metal detectors on implantable cardioverter devices (ICDs) and pacemakers, German investigators conclude that airport security ...

Though a Northwestern-developed quarter-size dissolvable pacemaker worked well in pre-clinical animal studies, cardiac surgeons asked if it was possible to make the device smaller. To reduce the size ...

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. Pacemakers are not designed or approved to provide ...